IB Acquisition IBAC
NASDAQ IBAC
$10.88 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

IB Acquisition (IBAC) Liabilities and Shareholders Equity (2023 - 2026)

IB Acquisition's (IBAC) quarterly Liabilities and Shareholders Equity came in at $8.5 million in Q1 2026, down 93.0% YoY from $121.2 million in Q1 2025, and down 48.32% on a QoQ basis from $16.4 million in Q4 2025.

IB Acquisition (IBAC) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

IB Acquisition (IBAC) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $8.5 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 93.0% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $164.2 million (down 65.81% YoY) and the FY2025 annual result came in at $17.1 million, down 85.7% from the prior year.
  • Liabilities and Shareholders Equity declined to $8.5 million in Q1 2026, from $16.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $122.2 million in Q2 2025 to a low of $52553.0 in Q3 2023.
  • A 4-year average of $76.2 million and a median of $117.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity jumped 227861.08% — and 2026, when it tumbled 93.0%.
  • Tracing IBAC's Liabilities and Shareholders Equity over 4 years: stood at $52553.0 in 2023, then surged by 229823.22% to $120.8 million in 2024, then sank by 86.42% to $16.4 million in 2025, then sank by 48.32% to $8.5 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $8.5 million (Q1 2026), $16.4 million (Q4 2025), and $17.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 261.48 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 245.80 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 514.10 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 464.99 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 98.35 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 247.73 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 314.37 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 374.60 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 376.80 Mn
10 IB Acquisition 46.23 Mn 46.20 Mn - 8.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.48 Mn
Dec 31, 2025 16.41 Mn
Sep 30, 2025 17.13 Mn
Jun 30, 2025 122.18 Mn
Mar 31, 2025 121.16 Mn
Dec 31, 2024 120.83 Mn
Sep 30, 2024 119.80 Mn
Jun 30, 2024 118.39 Mn
Mar 31, 2024 117.27 Mn
Sep 30, 2023 52,553.00